Beacon Capital Management LLC (Tennessee)’s Anavex Life Sciences AVXL Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-110	Closed	-$1.01K	–	194
2025 Q2	$1.01K	Hold	110	–	–	﹤0.01%	981
2025 Q1	$944	Hold	110	–	–	﹤0.01%	1042
2024 Q4	$1.18K	Hold	110	–	–	﹤0.01%	968
2024 Q3	$625	Hold	110	–	–	﹤0.01%	1136
2024 Q2	$464	Hold	110	–	–	﹤0.01%	1000
2024 Q1	$560	Sell	110 -56	-34%	-$315	﹤0.01%	1001
2023 Q4	$1.09K	Hold	166	–	–	﹤0.01%	864
2023 Q3	$1.35K	Hold	166	–	–	﹤0.01%	887
2023 Q2	$1.35K	Hold	166	–	–	﹤0.01%	887
2023 Q1	$1.42K	Hold	166	–	–	﹤0.01%	800
2022 Q4	$1.54K	Hold	166	–	–	﹤0.01%	834
2022 Q3	$2K	Hold	166	–	–	﹤0.01%	711
2022 Q2	$2K	Hold	166	–	–	﹤0.01%	764
2022 Q1	$2K	Buy	+166	New	+$2.04K	﹤0.01%	765

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s AVXL Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Anavex Life Sciences (AVXL) in Q3 2025, closing a stake of 110 shares — an estimated $1.01K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in AVXL in Q1 2022 and held it in 14 quarters. The position peaked at $2K in Q3 2022. 186 funds tracked by Wall St. Rank hold AVXL as of Q3 2025.

Beacon Capital Management LLC (Tennessee) reported no remaining Anavex Life Sciences position as of Q3 2025 after selling out during the quarter.
Beacon Capital Management LLC (Tennessee) sold 110 Anavex Life Sciences shares in Q3 2025, an estimated $1.01K.
Beacon Capital Management LLC (Tennessee) first reported a position in Anavex Life Sciences in Q1 2022 and held it in 14 quarters.
Beacon Capital Management LLC (Tennessee)'s Anavex Life Sciences position peaked at $2K in Q3 2022.
186 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.